Reena Mehta, MD
Allergy & Immunology · New Orleans, LANPI 1316263858
Payments from drug & device makers
Across 576 payments — averaging $275.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$82K
- Sanofi$46K
- Amgen$13K
- Genentech USA, Inc.$12K
- GSK$2K
- Regeneron Healthcare Solutions, Inc.$529
- plus $3K from 27 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 160 | $82,463 |
| Sanofi | 63 | $45,735 |
| Amgen | 16 | $12,837 |
| Genentech USA, Inc. | 43 | $12,207 |
| GSK | 119 | $1,976 |
| Regeneron Healthcare Solutions, Inc. | 28 | $529 |
| Pfizer | 25 | $466 |
| Takeda Pharmaceuticals U.S.A., Inc. | 22 | $407 |
| AbbVie | 13 | $361 |
| Novartis | 13 | $270 |
| Galderma Laboratories, L.p. | 11 | $257 |
| Kaleo, Inc. | 9 | $146 |
| Aimmune Therapeutics, Inc. | 5 | $130 |
| Grifols USA, LLC | 5 | $115 |
| Alk-abello, Inc | 6 | $96 |
| CSL Behring | 6 | $90 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $68 |
| Teva Pharmaceuticals USA, Inc. | 4 | $66 |
| Sanofi-aventis U.S. LLC | 1 | $65 |
| Biocryst US Sales Co., LLC | 2 | $43 |
| LEO Pharma Inc. | 2 | $41 |
| Hikma Pharmaceuticals USA | 2 | $38 |
| Phadia US Inc. | 2 | $35 |
| ADMA Biomanufacturing LLC | 2 | $34 |
| Optinose US, Inc. | 2 | $33 |
| Boehringer Ingelheim | 2 | $31 |
| Incyte Corporation | 2 | $27 |
| Azurity Pharmaceuticals, Inc. | 1 | $26 |
| Organon | 3 | $23 |
| Blueprint Medicines Corporation | 1 | $23 |
| Pharming Healthcare, Inc. | 1 | $18 |
| Shire North American Group Inc | 1 | $16 |
| Cycle Pharmaceuticals Inc | 1 | $12 |
How this compares
$158,684 in reported general payments places this provider in the 95th percentile of 62 allergy & immunology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other allergy & immunology in New Orleans
- Kenneth ParisNew Orleans$266K
- William DavisNew Orleans$33K
- Michelle Korah-SedgwickNew Orleans$28K
- Cheryl WilliamsNew Orleans$27K
- John CarlsonNew Orleans$22K
- Luke WallNew Orleans$14K
- Laurianne WildNew Orleans$4K
- Stephen DerbesNew Orleans$2K
- Jamie LurieNew Orleans$2K
- Elizabeth WisnerNew Orleans$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.